Auriga
Auriga USA is a research and trading platform that focuses on growth sectors within the Health Care and Technology verticals. We operate out of our main office in New York City, and also have satellite offices in Boston, San Francisco, Philadelphia, San Diego, and Washington D.C. This regional network helps us to keep abreast of key corporate developments, enhance client relationships, and provide more efficient product distribution to meet clients' investment needs. The firm is committed to providing our clients with critical information flow, investment ideas, and access to industry experts.
View Older Stories View More Recent Stories
-
MyTeller Solution - A Step by Step Approach to Branch Transformation
-
Gamida Cell Announces Appointment of Julian Adams, Ph.D. and Kenneth I. Moch to its Board of Directors
-
Arno Completes $2.8 Million Private Placement
-
Gamida Cell Announces First Patient with Sickle Cell Disease Transplanted in Phase 1/2 Study of CordIn™ as the Sole Graft Source
-
H1 2016 Sales: +7% to EUR 8.9m
-
SuperSonic Imagine: H1 2016 Sales: +7% to €8.9m
-
SuperSonic Imagine Announces the Completion of Patient Enrollment for Pivotal Liver Fibrosis Clinical Study in China
-
SuperSonic Imagine Announces the Completion of Patient Enrollment for Pivotal Liver Fibrosis Clinical Study in China
-
Gamida Cell Presents Data From Phase 1/2 Study of NiCord® for High Risk Hematological Malignancies at ASCO 2016
-
SuperSonic Imagine Receives Regulatory Approval in Japan for New Advancements on the Aixplorer(R) Ultrasound System
-
Supersonic Imagine Receives Regulatory Approval in Japan for New Advancements on the Aixplorer® Ultrasound System
-
Gamida Cell Announces $4.4 Million Grant from the Israeli Government
-
Theranexus Reaches Its Primary Endpoint in the Proof of Concept Trial of THN102 in Excessive Daytime Sleepiness (EDS)
-
SuperSonic Imagine's Advanced Ultrasound Technology Adopted by Sports Medicine Professionals
-
SuperSonic Imagine’s Advanced Ultrasound Technology Adopted by Sports Medicine Professionals
-
Capella Hotel Group Asia to Manage Heritage "Shikumen" Landmark in Shanghai
-
SuperSonic Imagine to Demonstrate Its Non-Invasive, 60-Second Liver Assessment Exam at the International Liver Congress(TM) (ILC 2016) Barcelona, Spain
-
SuperSonic Imagine to Demonstrate its Non-Invasive, 60-Second Liver Assessment Exam at the International Liver Congress™ (ILC 2016) Barcelona, Spain
-
SuperSonic Imagine Showcases Breast Imaging Innovations at Key Conferences
-
SuperSonic Imagine Showcases Breast Imaging Innovations at Key Conferences
-
Gamida Cell Presents Additional Positive Data of NiCord® in Blood Cancer Patients at EBMT 2016
-
Theranexus: Preclinical Results Published in the Specialist Medical Journal Sleep
-
SuperSonic Imagine Showcases Clinical Innovations During the European Congress of Radiology
-
SuperSonic Imagine Showcases Clinical Innovations During the European Congress of Radiology
-
Forbes Travel Guide Announces 2016 Star Rating Awards
-
Zeitgeist Inc. Launches on Touch of Modern to Introduce Lightweight, Luxury Electric City Bike
-
Auberge Resorts Collection Appoints Shirley Dunn Hanks Director of Sales and Marketing for Vievage Los Cabos
-
SuperSonic Imagine Highlights the Clinical Benefits of Real-Time ShearWave Elastography in the Middle East
-
SuperSonic Imagine Highlights the Clinical Benefits of Real-Time ShearWave Elastography in the Middle East
-
SuperSonic Imagine: 2015 Annual Sales: +2% to €20.1 Million
-
Arno Therapeutics Completes $7.4 Million Common Stock Financing
-
SuperSonic Imagine Announces Its 2016 Financial Calendar
-
SuperSonic Imagine Installs Aixplorer(R) Ultrasound System at the Brust-Zentrum Breast Centre in Zurich, Switzerland
-
SuperSonic Imagine Installs Aixplorer® Ultrasound System at the Brust-Zentrum Breast Centre in Zürich, Switzerland
-
SuperSonic Imagine Appoints Bernard Doorenbos as Interim President and Chief Executive Officer
-
SuperSonic Imagine Appoints Bernard Doorenbos as Interim President and Chief Executive Officer
-
Gamida Cell Reports Positive Top Line Results of International, Multi-Center, Phase I/II Study of NiCord® for Blood Cancers, Demonstrating Rapid and Durable Hematopoietic Recovery
-
SDLP - Seadrill Partners LLC Announces Third Quarter 2015 Results
-
SuperSonic Imagine to Highlight Advancement in Microvascular Imaging at Annual Radiology Meeting
-
SuperSonic Imagine to Highlight Advancement in Microvascular Imaging at Annual Radiology Meeting
-
SuperSonic Imagine to Showcase Its Non-Invasive, 60-Second Liver Assessment Exam as an Alternative to Biopsy
-
SuperSonic Imagine to Showcase Its Non-Invasive, 60-Second Liver Assessment Exam as an Alternative to Biopsy
-
SuperSonic Imagine Announces Completion of Key Milestone in Largest ShearWave(TM) Elastography Breast Cancer Study
-
SuperSonic Imagine Announces Completion of Key Milestone in Largest ShearWaveTM Elastography Breast Cancer Study
-
ARCA to Demonstrate Assisted Self-Service Solution at RBR Branch Transformation 2015
-
ITG Investment Research Launches Coverage on Semiconductors
-
SuperSonic Imagine: Solid Q3 Product Sales Growth: +21%
-
SuperSonic Imagine to Demonstrate Breakthrough Ultrasensitive Technology for Microvascular Imaging for the First Time at the French Radiology Congress
-
SuperSonic Imagine To Demonstrate Breakthrough Ultrasensitive Technology for Microvascular Imaging for the First Time at the French Radiology Congress
-
Innovation unConference: Open Connections to Create a Boundless Future on October 23 at the Hynes
